Simona Halep, the defending champion in women's singles at Wimbledon, announced on Friday that she has withdrawn from this year's tournament due to an injury. Halep, the No. 3-ranked player in the ...

Simona Halep is allowed to resume her tennis career whenever she wants ... Roxadustat was approved for use in the European Union in 2021 to treat the symptoms of anemia caused by chronic kidney ...

Halep once stood atop women's tennis, winning major singles trophies ... Roxadustat was approved for use in the European Union in 2021 to treat the symptoms of anemia caused by chronic kidney ...

Simona Halep is allowed to resume her tennis career whenever she wants ... Roxadustat was approved for use in the European Union in 2021 to treat the symptoms of anemia caused by chronic kidney ...

Halep has been having a comeback this year, returning to the Women's Tennis Association Tour's top 10 in August. Before injuries and emotional exhaustion derailed her during the 2021 season ...

Simona Halep in happier times, celebrating a win at the 2021 US Open. Corey Sipkin for ... Halep’s case is tennis’ most high-profile doping controversy since Maria Sharapova was banned in ...

Two-time Grand Slam champion Simona Halep received a four-year suspension for breaching the Tennis Anti-Doping Program ... After a run to the quarterfinals at the 2021 Australian Open, Halep ...

Halep was in the top 10 for 373 consecutive weeks from 2014-2021, emerging as one of women’s tennis’ most consistent players, omnipresent in the latter stages of the world’s biggest tournaments.

Halep says it would likely spell the end of her tennis career ... by the pandemic in 2020 and then by a series of injuries in 2021 - which forced the Romanian to miss her Wimbledon defence ...

But the re-breakthrough is here now, and today Halep kicks off her 374th career week inside the Top 10. The first 373 all came consecutively between January 27th, 2014 and August 9th, 2021 ...

Simona Halep is allowed to resume her tennis career whenever she wants ... Roxadustat was approved for use in the European Union in 2021 to treat the symptoms of anemia caused by chronic kidney ...